REGENXBIO Inc.

RGNX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Period	Revenue	Operating Income	Net Income
Mar 2014	$2.9M	$835.0K	$795.0K
Jun 2014	$1.5M	$-601.0K	$-672.0K
Sep 2014	$483.0K	$-1.7M	$-1.8M
Dec 2014	$1.2M	$-2.2M	$-2.3M
Mar 2015	$644.0K	$-4.0M	$-4.0M
Jun 2015	$1.4M	$-6.3M	$-6.3M
Sep 2015	$1.1M	$-7.3M	$-7.3M
Dec 2015	$4.4M	$-5.5M	$-5.2M
Mar 2016	$393.0K	$-11.3M	$-10.8M
Jun 2016	$2.4M	$-15.0M	$-14.4M
Sep 2016	$125.0K	$-18.7M	$-18.2M
Dec 2016	$1.7M	$-20.5M	$-19.6M
Mar 2017	$455.0K	$-22.9M	$-22.0M
Jun 2017	$6.6M	$-15.1M	$-14.5M
Sep 2017	$1.3M	$-21.3M	$-20.7M
Dec 2017	$2.0M	$-16.6M	$-16.0M
Mar 2018	$132.4M	$102.0M	$104.2M
Jun 2018	$40.0M	$6.4M	$10.6M
Sep 2018	$5.3M	$-22.7M	$-19.2M
Dec 2018	$40.8M	$2.5M	$4.3M
Mar 2019	$884.0K	$-35.9M	$-32.2M
Jun 2019	$7.9M	$-36.9M	$-1.5M
Sep 2019	$14.7M	$-35.9M	$-34.6M
Dec 2019	$11.8M	$-40.3M	$-26.5M
Mar 2020	$17.6M	$-37.7M	$-40.0M
Jun 2020	$16.6M	$-41.8M	$-33.8M
Sep 2020	$98.9M	$14.0M	$8.8M
Dec 2020	$21.4M	$-53.7M	$-46.2M
Mar 2021	$18.9M	$-44.0M	$-50.1M
Jun 2021	$22.0M	$-52.2M	$-57.6M
Sep 2021	$30.8M	$-57.3M	$-58.4M
Dec 2021	$398.7M	$313.6M	$294.0M
Mar 2022	$22.2M	$-71.5M	$-76.7M
Jun 2022	$32.6M	$-62.5M	$-68.2M
Sep 2022	$26.5M	$-71.0M	$-75.5M
Dec 2022	$31.3M	$-57.8M	$-59.9M
Mar 2023	$19.1M	$-66.2M	$-66.7M
Jun 2023	$20.0M	$-73.1M	$-72.1M
Sep 2023	$28.9M	$-65.0M	$-61.9M
Dec 2023	$22.2M	$-63.9M	$-62.9M
Mar 2024	$15.6M	$-63.9M	$-63.3M
Jun 2024	$22.3M	$-56.0M	$-53.0M
Sep 2024	$24.2M	$-62.1M	$-59.6M
Dec 2024	$21.2M	$-51.4M	$-51.2M
Mar 2025	$89.0M	$12.1M	$6.1M
Jun 2025	$21.4M	$-63.3M	$-70.9M
Sep 2025	$29.7M	$-52.4M	$-61.9M
Dec 2025	$30.3M	$-57.6M	$-67.1M
Mar 2026	$6.4M	$-83.4M	$-90.1M
Jun 2026	$108.0M	$29.3M	$22.7M